Join
Live feed
·
PRReleasevia Quantisnow
Amneal Pharmaceuticals Inc. logo

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's Disease

ByQuantisnow·Wall Street's wire, on your screen.
AMRX· Amneal Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRX (Amneal Pharmaceuticals Inc.) and more on Quantisnow.